The decision not to procure Evusheld ® at this time has been taken based on clinical advice, rather cost. The RAPID C-19 group is a collaborative UK-wide partnership between the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and others.